SERPANRAY Drug Patent Profile
✉ Email this page to a colleague
When do Serpanray patents expire, and what generic alternatives are available?
Serpanray is a drug marketed by Panray and is included in one NDA.
The generic ingredient in SERPANRAY is reserpine. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine profile page.
Summary for SERPANRAY
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Patent Applications: | 2,013 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SERPANRAY at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for SERPANRAY
US Patents and Regulatory Information for SERPANRAY
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Panray | SERPANRAY | reserpine | TABLET;ORAL | 009391-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |